Patents by Inventor Dennis Heyer

Dennis Heyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VIBRATION DAMPER, BICYCLE FORK, SPRING STRUT, AND USE OF A VIBRATION DAMPER
    Publication number: 20240149970
    Abstract: A vibration damper with amplitude-dependent damping, with a cylindrical compensation space attached fluidically, in parallel to the vibration damper and is split by way of a displaceable separating piston, the vibration damper comprising a working piston, the working piston being received displaceably in a damper tube, the working piston dividing the damper tube into a first damping space and a second damping space, the separating piston being received axially displaceably in the compensation space, the separating piston dividing the compensation space into a first part space and a second part space, the first part space being connected fluidically to the first damping space, the second part space being connected fluidically to the damping space, the vibration damper being equipped with a throttle device for influencing the fluid flow between the first part space and the first damping space and/or between the second part space and the second damping space.
    Type: Application
    Filed: October 27, 2023
    Publication date: May 9, 2024
    Applicants: thyssenkrupp Bilstein GmbH, thyssenkrupp AG
    Inventors: Michael HEYER, Hanno LUCZAK, Dennis GUNDLACH, Daniel HANSEN
  • FATTY ACID SYNTHASE INHIBITORS
    Publication number: 20130196971
    Abstract: This invention relates to the use of imidazole, triazole, and tetrazole derivatives for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of imidazoles, triazoles, and tetrazoles in the treatment of cancer.
    Type: Application
    Filed: September 15, 2011
    Publication date: August 1, 2013
    Inventors: Christopher Joseph Aquino, Dennis Heyer, Terence John Kiesow, David Lee Musso, Cynthia A. Parrish
  • Chemical compounds
    Patent number: 8222261
    Abstract: The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly Type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
    Type: Grant
    Filed: January 13, 2009
    Date of Patent: July 17, 2012
    Assignee: GlaxoSmithKline, LLC
    Inventors: Subba R Katamreddy, Richard Dama Caldwell, Dennis Heyer, Vincente Samano, James Benjamin Thompson, Andrew J Carpenter, Christopher R Conlee, Eric Eugene Boros, Brian D Thompson
  • Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators
    Publication number: 20100261772
    Abstract: The present invention relates to compounds of formula (I) with a variety of therapeutic uses, more particularly the substituted cyclic alkylidene compounds are useful for selective estrogen receptor modulation.
    Type: Application
    Filed: May 24, 2010
    Publication date: October 14, 2010
    Inventors: Jing Fang, Dennis Heyer, Subba Reddy Katamreddy, Kenneth William Batchelor, Richard Dana Caldwell
  • Cycloalkylidene compounds as modulators of estrogen receptor
    Patent number: 7799828
    Abstract: The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
    Type: Grant
    Filed: June 8, 2009
    Date of Patent: September 21, 2010
    Assignee: GlaxoSmithKline LLC
    Inventors: Jing Fang, Dennis Heyer, Aaron Bayne Miller, Frank Navas, III, Terrence Lee Smalley, Jr., William J. Zuercher, Subba Reddy Katamreddy
  • Cycloalkylidene compounds as selective estrogen receptor modulators
    Patent number: 7723393
    Abstract: The present invention relates to compounds of formula (I) with a variety of therapeutic uses, more particularly the substituted cyclic alkylidene compounds are useful for selective estrogen receptor modulation.
    Type: Grant
    Filed: May 24, 2006
    Date of Patent: May 25, 2010
    Assignee: GlaxoSmithKline LLC
    Inventors: Jing Fang, Dennis Heyer, Subba Reddy Katamreddy, Kenneth William Batchelor, Richard Dana Caldwell
  • Naphthalene compounds as selective estrogen receptor modulators
    Patent number: 7649093
    Abstract: The present invention relates to cycloalkylidene compounds with a variety of therapeutic uses, more particularly novel naphthalene compounds that are particularly useful for selective estrogen receptor modulation.
    Type: Grant
    Filed: June 21, 2005
    Date of Patent: January 19, 2010
    Assignee: Glaxo Smith Kline LLC
    Inventors: Dennis Heyer, Jing Fang, Frank Navas, III, Subba Reddy Katamreddy, Jennifer Poole Peckham, Philip Stewart Turnbull, Aaron Bayne Miller, Adwoa Akwabi-Ameyaw
  • Cycloalkylidene Compounds As Modulators of Estrogen Receptor
    Publication number: 20090253659
    Abstract: The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
    Type: Application
    Filed: June 8, 2009
    Publication date: October 8, 2009
    Inventors: Jing Fang, Dennis Heyer, Aaron Bayne Miller, Frank Navas, III, Terrence Lee Smalley, JR., William J. Zuercher, Subba Reddy Katamreddy
  • Cycloalkylidene compounds as modulators of estrogen receptor
    Patent number: 7569601
    Abstract: The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
    Type: Grant
    Filed: May 14, 2007
    Date of Patent: August 4, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Jing Fang, Dennis Heyer, Aaron Bayne Miller, Frank Navas, III, Terrence Lee Smalley, Jr., William J. Zuercher, Subba Reddy Katamreddy
  • Cycloalkylidene compounds as modulators of estrogen receptor
    Patent number: 7560589
    Abstract: The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
    Type: Grant
    Filed: July 27, 2004
    Date of Patent: July 14, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Jonathan E. Britton, Jing Fang, Dennis Heyer, Aaron Bayne Miller, Frank Navas, III, Terrence Lee Smalley, Jr., William J. Zuercher, Subba Reddy Katamreddy
  • Triphenylethylene compounds as selective estrogen receptor modulators
    Patent number: 7442833
    Abstract: Compounds of formula (I): with a variety of therapeutic uses, more particularly novel prodrugs that are particularly useful for delivering a parent compound for selective estrogen receptor modulation.
    Type: Grant
    Filed: October 4, 2004
    Date of Patent: October 28, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: John Fred Eaddy, III, Dennis Heyer, Amarjit Sab Randhawa, Vicente Samano, John Albert Ray, Subba Reddy Katamreddy, Michael Tolar Martin, Michael Scott McClure
  • Cycloalkylidene Compounds as Selective Estrogen Receptor Modulators
    Publication number: 20080167360
    Abstract: The present invention relates to compounds of formula (I) with a variety of therapeutic uses, more particularly the substituted cyclic alkylidene compounds are useful for selective estrogen receptor modulation.
    Type: Application
    Filed: May 24, 2006
    Publication date: July 10, 2008
    Inventors: Jing Fang, Dennis Heyer, Subba Reddy Katamreddy, Kenneth William Batchelor, Richard Dana Caldwell
  • CHEMICAL COMPOUNDS
    Publication number: 20070276000
    Abstract: The present invention relates to cycloalkylidene compounds with a variety of therapeutic uses, more particularly novel naphthalene compounds that are particularly useful for selective estrogen modulation.
    Type: Application
    Filed: June 21, 2005
    Publication date: November 29, 2007
    Inventors: Dennis Heyer, Jing Fang, Frank Navas III, Subba Katamreddy, Jennifer Peckham, Philip Turnbull, Aaron Miller, Adwoa Akwabi-Ameyan, Charles Dadswell
  • Chemical Compounds
    Publication number: 20070213348
    Abstract: The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
    Type: Application
    Filed: May 14, 2007
    Publication date: September 13, 2007
    Inventors: Jonathan Britton, Jing Fang, Dennis Heyer, Aaron Miller, Frank Navas, Terrence Smalley, William Zuercher, Subba Katamreddy
  • Cycloalkylidene compounds as modulators of estrogen receptor
    Publication number: 20070155839
    Abstract: The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
    Type: Application
    Filed: July 27, 2004
    Publication date: July 5, 2007
    Inventors: Jonathan Britton, Jing Fang, Dennis Heyer, Aaron Miller, Frank Navas, Terrence Smalley, William Zuercher, Subba Katamreddy
  • Novel compounds
    Publication number: 20070111971
    Abstract: Compounds of formula (I): with a variety of therapeutic uses, more particularly novel prodrugs that are particularly useful for delivering a parent compound for selective estrogen receptor modulation.
    Type: Application
    Filed: October 4, 2004
    Publication date: May 17, 2007
    Inventors: John Eaddy, Dennis Heyer, Amarjit Randhawa, Vicente Sanano, John Ray, Subba Katamreddy, Michael Martin, Michael McClure
  • Phenoxathin derivatives as inhibitors of monoamine oxidase
    Patent number: 6110961
    Abstract: The present invention provide phenoxathiin compounds useful in the prophylaxis and treatment of mental disorders, such as depression. The present invention also provides a method for treating a mammal having depression, anxiety or other conditions responsive to inhibition of MAO-A. A method of preparing the compounds of the present invention is also provided.
    Type: Grant
    Filed: March 11, 1999
    Date of Patent: August 29, 2000
    Assignee: Krenitsky Pharmaceuticals, Inc.
    Inventors: Helen Lyng White, deceased, Morton Harfenist, Eric Boros, Dennis Heyer
  • Neuropeptide Y antagonists
    Patent number: 5670482
    Abstract: The present invention relates to peptides which show improved Neuropeptide Y antagonism to pharmaceutical compositions containing such peptides and their use.
    Type: Grant
    Filed: February 17, 1995
    Date of Patent: September 23, 1997
    Assignee: Glaxo Wellcome Inc.
    Inventors: Alejandro Jose Daniels, Dennis Heyer, Antonio Landavazo, Johann Jakob Leban, Andreas Spaltenstein